These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36369199)

  • 21. The severity of histopathological changes of leukocytoclastic vasculitis is not predictive of extracutaneous involvement.
    Cribier B; Couilliet D; Meyer P; Grosshans E
    Am J Dermatopathol; 1999 Dec; 21(6):532-6. PubMed ID: 10608245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct immunofluorescence in cutaneous vasculitis: experience from a referral hospital in India.
    Nandeesh B; Tirumalae R
    Indian J Dermatol; 2013 Jan; 58(1):22-5. PubMed ID: 23372207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients.
    Sais G; Vidaller A; Jucglà A; Servitje O; Condom E; Peyri J
    Arch Dermatol; 1998 Mar; 134(3):309-15. PubMed ID: 9521029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approach to cutaneous vasculitides with special emphasis on small vessel vasculitis: histopathology and direct immunofluorescence.
    Demirkesen C
    Curr Opin Rheumatol; 2017 Jan; 29(1):39-44. PubMed ID: 27787337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocytoclastic Vasculitis in a Patient With Crohn Disease: A Case Report.
    Bugada MD; Emani VK
    J Investig Med High Impact Case Rep; 2023; 11():23247096231181865. PubMed ID: 37357841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous and systemic vasculitides in dermatology: a histological perspective.
    Alberti-Violetti S; Berti E; Marzano AV
    G Ital Dermatol Venereol; 2018 Apr; 153(2):185-193. PubMed ID: 29368866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous vasculitides: clinico-pathological correlation.
    Gupta S; Handa S; Kanwar AJ; Radotra BD; Minz RW
    Indian J Dermatol Venereol Leprol; 2009; 75(4):356-62. PubMed ID: 19584459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of leukocytoclastic vasculitis.
    Sunderkötter C; Bonsmann G; Sindrilaru A; Luger T
    J Dermatolog Treat; 2005; 16(4):193-206. PubMed ID: 16249140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of cutaneous immunoreactants in lesional skin with the serological disorders and disease activity of systemic lupus erythematosus.
    Luo YJ; Tan GZ; Yu M; Li KW; Liu YY; Guo Q; Zeng FQ; Wang L
    PLoS One; 2013; 8(8):e70983. PubMed ID: 23940681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis.
    Naylor E; Atwater A; Selim MA; Hall R; Puri PK
    Arch Dermatol; 2011 Nov; 147(11):1313-6. PubMed ID: 22106118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of cutaneous vasculitis in adult patients from the Farwaniya region of Kuwait.
    Al-Mutairi N
    Med Princ Pract; 2008; 17(1):43-8. PubMed ID: 18059100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of direct immunofluorescence test panels for cutaneous vasculitis: A scoping review.
    Lehman JS; Ferringer TC; Fung MA; Cassarino DS; Shalin SC
    J Cutan Pathol; 2024 Dec; 51(12):987-999. PubMed ID: 39307568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythema multiforme-like manifestations and arthritis in a 3-year-old child with leukocytoclastic vasculitis.
    Gattorno M; Picco P; Gambini C; Buoncompagni A; Castagnola E; Pistoia V; Borrone C
    Clin Exp Rheumatol; 1997; 15(3):329-32. PubMed ID: 9177932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urticarial vasculitis.
    Cardoso PA; de Oliveira ZP; Alves VA; Candelori I; Croce J; Rivitti EA
    Allergol Immunopathol (Madr); 1990; 18(4):191-5. PubMed ID: 2264552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis.
    Goeser MR; Laniosz V; Wetter DA
    Am J Clin Dermatol; 2014 Aug; 15(4):299-306. PubMed ID: 24756249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Clinical and Laboratory Use of the Cutaneous Direct Immunofluorescence Assay.
    Reimann JDR; Moynihan SP; Horn TD
    JAMA Dermatol; 2021 Nov; 157(11):1343-1348. PubMed ID: 34613346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia.
    Lulla P; Bandeali S; Baker K
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S14-6. PubMed ID: 22035741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis.
    Gyselbrecht L; De Keyser F; Ongenae K; Naeyaert JM; Praet M; Veys EM
    Clin Exp Rheumatol; 1996; 14(6):665-8. PubMed ID: 8978964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo confocal laser scanning microscopy: An innovative method for direct immunofluorescence of cutaneous vasculitis.
    Bağcı IS; Aoki R; Krammer S; Ruzicka T; Sárdy M; Hartmann D
    J Biophotonics; 2019 Sep; 12(9):e201800425. PubMed ID: 31021054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus (HCV) in cryoglobulinaemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression?
    Bernacchi E; Civita LL; Caproni M; Zignego AL; Bianchi B; Monti M; Fabbri P; Pasero G; Ferri C
    Exp Dermatol; 1999 Dec; 8(6):480-6. PubMed ID: 10597137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.